Yadong Yu

Yadong Yu is a Senior Scientist at NGM Biopharmaceuticals since August 2022, specializing in antibody discovery using phage display techniques. Prior experience includes positions at Nektar Therapeutics, where critical biophysics analysis contributed to early drug development, and TrueBinding, focusing on biosensor characterization. Yu's tenure at LakePharma involved protein purification and process development, while research at Berkeley Lab centered on human plasma lipoproteins, resulting in notable publications. Postdoctoral experiences at UCSF and the National Institutes of Health included significant studies on proteasome mechanisms and receptor interactions. Yadong Yu holds a PhD in Biochemistry and Molecular Biology from the Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, and a bachelor's degree in pharmaceutics from China Pharmaceutical University.